Raynaud's disease.
We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.
Burns
E C
EC
Dunger
D B
DB
Dillon
M J
MJ
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002648:Child; D015232:Dinoprostone / Q000031:analogs & derivatives*; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007650:Ketanserin; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy* / Q000473:pathology
D000959:Antihypertensive Agents; D010880:Piperidines; D011459:Prostaglandins E, Synthetic; D010643:Phenoxybenzamine; D009599:Nitroprusside; D007650:Ketanserin; D011464:Epoprostenol; D009543:Nifedipine; D015232:Dinoprostone; C034232:viprostol